![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Goldstein L.B.
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.22, Iss.1, 2000-01, pp. : 13-18
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Venomous solution to acute ischaemic stroke?
Inpharma, Vol. 1, Iss. 1238, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
How best to prevent ischaemic stroke?
Inpharma, Vol. 1, Iss. 1268, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
What's new with alteplase in stroke?
Inpharma, Vol. 1, Iss. 1229, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
`Doom and gloom' for neuroprotectants in stroke?
Inpharma, Vol. 1, Iss. 1241, 2000-01 ,pp. :